Time course of the tilorone-induced lysosomal accumulation of sulphated glycosaminoglycans in cultured fibroblasts.
Dicationic amphiphilic drugs such as the immunomodulator tilorone [2,7-bis-[2-(diethylamino)ethoxy]fluoren-9-one] are accumulated in lysosomes and disturb the degradation of sulphated glycosaminoglycans (GAGs) thus leading to generalized lysosomal GAG storage (mainly dermatan sulphate) in vivo and in cultured cells. In the present study, the time course of the tilorone-induced GAG storage was determined in cultured bovine corneal fibroblasts by a radiochemical approach and by morphological examination. In contrast to the rapid lysosomal accumulation of the drug as reported previously, it took approximately 42 h to reach 50% of the GAG storage obtained after 96 h. This is thought to be due to the fact that the temporal development of storage of undigested GAGs depends on the natural delivery of GAGs towards the lysosomal apparatus.
Department of Pharmacology, University of Kiel, Germany.
F
F
Bispinck
J
J
Fischer
R
R
Lüllmann-Rauch
M W
MW
Ziegenhagen
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D002417:Cattle; D002478:Cells, Cultured; D002809:Chondroitin Sulfates / Q000378:metabolism*; D003315:Cornea / Q000166:cytology / Q000187:drug effects*; D003871:Dermatan Sulfate / Q000378:metabolism*; D005347:Fibroblasts / Q000187:drug effects; D006497:Heparan Sulfate / Q000378:metabolism*; D008247:Lysosomes / Q000378:metabolism* / Q000648:ultrastructure; D013994:Tilorone / Q000494:pharmacology*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006497:Heparan Sulfate; D013994:Tilorone